Discontinuing GLP-1 therapy often leads to a reversal of its benefits, particularly for weight loss
Cell 117(3):399412 Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors
This requires careful nutritional assessment and monitoring, especially in younger adults or those with a history of eating disorders
Do not have the horse tied up
Pharmacokinetics analysis conducted in mice revealed a plasma half-life of 8 h and an intrinsic clearance rate of 11.54 ml/min/mg in mouse liver microsomes
Only if the weight loss is prescribed to treat a documented medical condition, such as clinical obesity with a comorbidity, cardiovascular disease, or hypertension